Fri, 30 Apr 2021 07:00:08 GMT
Gilead Q1 profit surges
Gilead Sciences reported its Q1 product sales soared 16%, including $1.46B in sales of Remdesivir, the company's COVID-19 antiviral drug, but warned the sales of its hepatitis C and HIV drugs were down amid the pandemic.